ArticleScientific reports2024

Incidence and determinants of adverse events in individuals with HIV commencing Dolutegravir-based antiretroviral therapy in mainland Tanzania.

Adam Fimbo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.